Suppliers / Aurolife Pharma

Aurolife Pharma

United States Updated 9 July 2026

Aurolife Pharma is a finished-dose manufacturer based in United States. It appears in 76 regulatory filings across 1 regulator, without an active US DMF or CEP on file. Its most recent recorded inspection, by US FDA, closed on 26 August 2022 as VAI.

0
active US DMFs
0
valid CEPs
2
registered plants 2 with an FDA FEI number
76
filings across 1 regulators
These figures were checked against the regulators' own files on 25 July 2026
Plants
2 of 2 confirmed
Inspections
8 of 8 confirmed
Sources: FDA Establishment Registration, read 4 May 2026. FDA drug inspection classifications, read 4 May 2026.

Inspection history

  • 26 August 2022 VAI US FDA
  • 7 December 2021 OAI US FDA
  • 22 October 2019 VAI US FDA
  • 14 June 2018 VAI US FDA
  • 28 July 2016 NAI US FDA
  • 12 January 2016 NAI US FDA
  • 9 July 2015 NAI US FDA
  • 15 October 2013 VAI US FDA

NAI means no action indicated, VAI means voluntary action indicated, and OAI means official action indicated.

Registered plants

Site FDA FEI
Dayton, United States 3005796917
Durham, United States 3014028588

Filings and GMP by regulator

Regulator Filings GMP certificates
US FDA 76 None

Questions about Aurolife Pharma

Does Aurolife Pharma hold a US DMF or a CEP?
No active US drug master file or valid CEP is on record for Aurolife Pharma. It does have 76 filings with one regulator, so it is registered, just not with the two strong registers buyers usually screen on.
Is Aurolife Pharma FDA-registered?
2 sites operated by Aurolife Pharma carry an FDA establishment identifier (FEI), which means they are registered with the FDA as a drug establishment. Registration is not the same as approval or inspection clearance.
How did Aurolife Pharma's last inspection go?
The most recent inspection on record closed on 26 August 2022 as VAI (Voluntary Action Indicated: issues were found but did not warrant regulatory action). 8 inspections are on file, of which 1 closed as OAI.
Where does Aurolife Pharma manufacture?
2 registered sites are on record, in United States (Dayton and Durham). Every site is listed on this page with the register it came from.
Where does Aurolife Pharma file?
Filings are on record with US FDA, 76 in total.

Answered from this company's own record. Where a register holds nothing, the question is not asked rather than answered with a zero. How we count our figures.

Comparing suppliers?

Choose your molecules and target markets. Aurolife Pharma comes back tiered against every other supplier able to file there.

Start for free
No sales call.

Open risk flags

  • 68 active litigation matters are on record.
  • The most recent inspection outcome was VAI, on 26 August 2022.

Comparable suppliers

Aaa Pharmaceuticals also in United States Aarkish Pharmaceuticals NJ also in United States Abbott Laboratories also in United States Abon Pharmaceuticals also in United States Access Business Group also in United States

Ranked by shared active ingredients where we have them, otherwise by country and comparable credentials.

Sources on this page

FDA
Drug master files, establishment registration, inspection classifications
EDQM
Certificates of suitability